Farhat FS - Search Results

1

Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma.

El Shamieh S, Saleh F, Fawaz MA, Siest G, Farhat FS, Visvikis-Siest S. El Shamieh S, et al. Among authors: farhat fs. Clin Chem Lab Med. 2017 Nov 27;56(1):e19-e22. doi: 10.1515/cclm-2017-0208. Clin Chem Lab Med. 2017. PMID: 28763293 No abstract available.

2

Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer.

El Shamieh S, Saleh F, Assaad S, Farhat F. El Shamieh S, et al. Drug Metab Pers Ther. 2019 May 30;34(2):/j/dmdi.2019.34.issue-2/dmpt-2018-0027/dmpt-2018-0027.xml. doi: 10.1515/dmpt-2018-0027. Drug Metab Pers Ther. 2019. PMID: 31145688

3

RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancer.

El Shamieh S, Saleh F, Moussa S, Kattan J, Farhat F. El Shamieh S, et al. Pharmacogenomics. 2018 Jun 1;19(9):757-760. doi: 10.2217/pgs-2018-0019. Epub 2018 May 23. Pharmacogenomics. 2018. PMID: 29790419

4

Detection of PIK3R1 (L449S) Mutation in a Patient with Ovarian Cancer: A Case Report.

Moussa S, Saleh F, El Shamieh S, Assi T, Othman A, Farhat F. Moussa S, et al. Case Rep Oncol. 2020 Feb 20;13(1):188-192. doi: 10.1159/000505723. eCollection 2020 Jan-Apr. Case Rep Oncol. 2020. PMID: 32231543 Free PMC article.

5

Triple-negative breast cancer in Lebanon: a case series.

Ghosn M, Hajj C, Kattan J, Farhat F, El Karak F, Nasr F, Abadjian G, Chahine G. Ghosn M, et al. Oncologist. 2011;16(11):1552-6. doi: 10.1634/theoncologist.2011-0088. Epub 2011 Oct 21. Oncologist. 2011. PMID: 22020211 Free PMC article.

6

Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.

Farhat F, Kattan JG, Ghosn M. Farhat F, et al. Cancer Chemother Pharmacol. 2016 May;77(5):1069-77. doi: 10.1007/s00280-016-3027-5. Epub 2016 Apr 8. Cancer Chemother Pharmacol. 2016. PMID: 27059339 Clinical Trial.

7

Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience.

Assi T, Kattan J, El Rassy E, Tabchi S, Chebib R, Moussa T, Hanna C, El Karak F, Farhat F, Ghosn M. Assi T, et al. J Cancer Res Ther. 2018 Jul-Sep;14(5):1112-1116. doi: 10.4103/0973-1482.183552. J Cancer Res Ther. 2018. PMID: 30197358 Free article.

8

Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.

Farhat FS, Kattan J, Ghosn MG. Farhat FS, et al. Expert Rev Anticancer Ther. 2010 Apr;10(4):541-8. doi: 10.1586/era.09.179. Expert Rev Anticancer Ther. 2010. PMID: 20397919 Review.

9

A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.

Farhat FS, Temraz S, Kattan J, Ibrahim K, Bitar N, Haddad N, Jalloul R, Hatoum HA, Nsouli G, Shamseddine AI. Farhat FS, et al. Clin Breast Cancer. 2011 Dec;11(6):384-9. doi: 10.1016/j.clbc.2011.08.005. Epub 2011 Oct 10. Clin Breast Cancer. 2011. PMID: 21993011 Clinical Trial.

10

The forgotten role of adjuvant immune checkpoint inhibitors in preventing melanoma brain metastasis.

El Rassy E, Farhat F, Kattan J. El Rassy E, et al. Immunotherapy. 2018 Nov;10(15):1289-1291. doi: 10.2217/imt-2018-0108. Immunotherapy. 2018. PMID: 30474477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters